Exploratory phase II study in patients after treatment of high grade brain tumors to assess the technical performance of Tc-99m tetrofosmin for differentiation of recurrence versus radiation necrosis
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Tetrofosmin (Primary)
- Indications Brain cancer
- Focus Diagnostic use
- Acronyms GLIOMARK1
- 16 Jul 2017 Planned number of patients changed from 30 to 51.
- 06 Feb 2017 This trial has been completed in Germany, according to European Clinical Trials Database.
- 02 Jun 2016 New trial record